US Stock MarketDetailed Quotes

Pacira BioSciences (PCRX)

Watchlist
  • 23.790
  • -0.030-0.13%
Close Apr 10 16:00 ET
  • 23.790
  • 0.0000.00%
Post 20:01 ET
963.25MMarket Cap148.69P/E (TTM)

Pacira BioSciences (PCRX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-19.75%151.99M
31.86%43.69M
12.82%60.83M
-77.44%12.01M
-27.78%35.46M
22.46%189.39M
-30.37%33.13M
21.34%53.92M
22.38%53.24M
156.70%49.1M
Net income from continuing operations
107.07%7.03M
-89.79%1.64M
103.79%5.43M
-125.66%-4.85M
-46.41%4.81M
-337.30%-99.56M
-35.50%16.04M
-1,421.29%-143.47M
-26.69%18.89M
145.96%8.98M
Operating gains losses
113.08%983K
--0
----
----
----
-144.42%-7.52M
--0
--0
----
----
Depreciation and amortization
15.53%91.02M
0.47%21.34M
4.63%21.19M
44.84%27.32M
14.88%21.17M
4.25%78.79M
14.92%21.24M
9.87%20.25M
-1.00%18.86M
-6.00%18.43M
Deferred tax
-68.59%6.48M
-206.73%-3.74M
623.95%8.07M
-94.00%752K
-59.66%1.4M
32.06%20.62M
-46.86%3.51M
-77.31%1.12M
9.55%12.54M
147.17%3.46M
Other non cash items
-53.88%-9.63M
-24.44%-3.75M
151.40%1.31M
-77.91%515K
-154.13%-7.7M
-195.74%-6.26M
19.00%-3.02M
-143.07%-2.54M
113.32%2.33M
-122.93%-3.03M
Change In working capital
-244.80%-38.27M
186.97%14.71M
-866.04%-16M
-771.20%-38.2M
-84.91%1.22M
73.06%-11.1M
-52.76%-16.91M
125.46%2.09M
29.39%-4.39M
151.59%8.11M
-Change in receivables
-38.64%-10.74M
30.45%-8.8M
-121.73%-897K
-205.79%-9.61M
118.51%8.56M
-8.23%-7.75M
-47.12%-12.65M
94.39%4.13M
46.54%-3.14M
-24.56%3.92M
-Change in inventory
-31.72%-27.57M
135.90%4.82M
-12.89%-9.51M
-116.30%-14.4M
-211.89%-8.47M
-152.46%-20.93M
-71.29%-13.42M
-91.96%-8.43M
-885.95%-6.66M
145.37%7.57M
-Change in prepaid assets
-2,086.89%-1.21M
98.45%12.7M
193.94%4.72M
-422.39%-11.52M
-892.75%-7.11M
101.20%61K
232.76%6.4M
-92.17%-5.03M
9.70%-2.21M
146.57%897K
-Change in payables and accrued expense
-92.84%1.26M
608.19%11.07M
-137.92%-4.48M
-263.62%-12.5M
304.45%7.17M
184.67%17.52M
-55.07%1.56M
483.83%11.82M
444.02%7.64M
84.42%-3.51M
-Change in other current liabilities
----
----
-1,338.52%-5.83M
51,800.00%9.82M
240.34%1.08M
525.35%2.71M
892.13%3.91M
-70.17%-405K
86.71%-19K
-283.14%-771K
Cash from discontinued investing activities
Operating cash flow
-19.75%151.99M
31.86%43.69M
12.82%60.83M
-77.44%12.01M
-27.78%35.46M
22.46%189.39M
-30.37%33.13M
21.34%53.92M
22.38%53.24M
156.70%49.1M
Investing cash flow
Cash flow from continuing investing activities
219.46%99.48M
5,353.53%19.33M
183.61%43.61M
508.56%62.16M
-65.03%-25.63M
-207.40%-83.28M
-104.39%-368K
-1,101.36%-52.16M
-307.68%-15.22M
-123.47%-15.53M
Net PPE purchase and sale
-44.16%-15.33M
89.71%-218K
5.43%-3.87M
-69.62%-2.7M
-201.41%-8.55M
29.85%-10.64M
-17.80%-2.12M
-20.57%-4.09M
53.29%-1.59M
56.80%-2.84M
Net business purchase and sale
---16.7M
--0
--0
--0
---16.7M
--0
--0
--0
--0
--0
Net investment purchase and sale
281.05%131.52M
1,017.20%19.55M
198.78%47.48M
576.04%64.86M
97.01%-379K
-178.36%-72.64M
-82.80%1.75M
-4,970.78%-48.07M
-226.98%-13.63M
-117.45%-12.69M
Cash from discontinued investing activities
Investing cash flow
219.46%99.48M
5,353.53%19.33M
183.61%43.61M
508.56%62.16M
-65.03%-25.63M
-207.40%-83.28M
-104.39%-368K
-1,101.36%-52.16M
-307.68%-15.22M
-123.47%-15.53M
Financing cash flow
Cash flow from continuing financing activities
-2,228.82%-369.63M
-2,542.05%-51.65M
-8,950.12%-257.48M
-330.20%-57.51M
-6.28%-2.99M
109.49%17.36M
-9.89%-1.96M
89.76%-2.85M
5,577.27%24.98M
98.17%-2.82M
Net issuance payments of debt
-382.97%-216.8M
-77.81%-5M
-7,195.98%-205.24M
-104.41%-3.75M
0.00%-2.81M
142.38%76.62M
0.00%-2.81M
89.89%-2.81M
3,123.57%85.05M
98.09%-2.81M
Net common stock issuance
-493.31%-148.33M
---48.25M
---50.04M
----
----
---25M
--0
--0
----
----
Proceeds from stock option exercised by employees
113.53%3.3M
84.37%1.72M
100.04%12K
----
----
-613.92%-24.41M
-18.00%934K
-106,936.00%-26.71M
-58.07%1.36M
--0
Net other financing activities
20.71%-7.8M
-63.64%-126K
-108.29%-2.21M
85.50%-5.29M
-4,425.00%-181K
-40.21%-9.84M
27.36%-77K
--26.68M
---36.44M
99.94%-4K
Cash from discontinued financing activities
Financing cash flow
-2,228.82%-369.63M
-2,542.05%-51.65M
-8,950.12%-257.48M
-330.20%-57.51M
-6.28%-2.99M
109.49%17.36M
-9.89%-1.96M
89.76%-2.85M
5,577.27%24.98M
98.17%-2.82M
Net cash flow
Beginning cash position
80.55%276.77M
-40.00%147.59M
21.63%300.48M
54.09%283.61M
80.55%276.77M
47.21%153.3M
148.15%245.97M
184.59%247.05M
417.80%184.05M
47.21%153.3M
Current changes in cash
-195.69%-118.15M
-63.10%11.37M
-13,965.07%-153.03M
-73.54%16.67M
-77.77%6.84M
151.18%123.48M
-43.13%30.81M
-108.84%-1.09M
22.89%63M
144.83%30.75M
Effect of exchange rate changes
---77K
---414K
--133K
----
----
--0
--0
--0
----
----
End cash Position
-42.72%158.55M
-42.72%158.55M
-40.00%147.59M
21.63%300.48M
54.09%283.61M
80.55%276.77M
80.55%276.77M
148.15%245.97M
184.59%247.05M
417.80%184.05M
Free cash flow
-23.55%136.66M
40.17%43.47M
14.32%56.96M
-81.96%9.32M
-41.83%26.91M
28.15%178.75M
-32.26%31.01M
21.40%49.83M
28.81%51.65M
268.26%46.27M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -19.75%151.99M31.86%43.69M12.82%60.83M-77.44%12.01M-27.78%35.46M22.46%189.39M-30.37%33.13M21.34%53.92M22.38%53.24M156.70%49.1M
Net income from continuing operations 107.07%7.03M-89.79%1.64M103.79%5.43M-125.66%-4.85M-46.41%4.81M-337.30%-99.56M-35.50%16.04M-1,421.29%-143.47M-26.69%18.89M145.96%8.98M
Operating gains losses 113.08%983K--0-------------144.42%-7.52M--0--0--------
Depreciation and amortization 15.53%91.02M0.47%21.34M4.63%21.19M44.84%27.32M14.88%21.17M4.25%78.79M14.92%21.24M9.87%20.25M-1.00%18.86M-6.00%18.43M
Deferred tax -68.59%6.48M-206.73%-3.74M623.95%8.07M-94.00%752K-59.66%1.4M32.06%20.62M-46.86%3.51M-77.31%1.12M9.55%12.54M147.17%3.46M
Other non cash items -53.88%-9.63M-24.44%-3.75M151.40%1.31M-77.91%515K-154.13%-7.7M-195.74%-6.26M19.00%-3.02M-143.07%-2.54M113.32%2.33M-122.93%-3.03M
Change In working capital -244.80%-38.27M186.97%14.71M-866.04%-16M-771.20%-38.2M-84.91%1.22M73.06%-11.1M-52.76%-16.91M125.46%2.09M29.39%-4.39M151.59%8.11M
-Change in receivables -38.64%-10.74M30.45%-8.8M-121.73%-897K-205.79%-9.61M118.51%8.56M-8.23%-7.75M-47.12%-12.65M94.39%4.13M46.54%-3.14M-24.56%3.92M
-Change in inventory -31.72%-27.57M135.90%4.82M-12.89%-9.51M-116.30%-14.4M-211.89%-8.47M-152.46%-20.93M-71.29%-13.42M-91.96%-8.43M-885.95%-6.66M145.37%7.57M
-Change in prepaid assets -2,086.89%-1.21M98.45%12.7M193.94%4.72M-422.39%-11.52M-892.75%-7.11M101.20%61K232.76%6.4M-92.17%-5.03M9.70%-2.21M146.57%897K
-Change in payables and accrued expense -92.84%1.26M608.19%11.07M-137.92%-4.48M-263.62%-12.5M304.45%7.17M184.67%17.52M-55.07%1.56M483.83%11.82M444.02%7.64M84.42%-3.51M
-Change in other current liabilities ---------1,338.52%-5.83M51,800.00%9.82M240.34%1.08M525.35%2.71M892.13%3.91M-70.17%-405K86.71%-19K-283.14%-771K
Cash from discontinued investing activities
Operating cash flow -19.75%151.99M31.86%43.69M12.82%60.83M-77.44%12.01M-27.78%35.46M22.46%189.39M-30.37%33.13M21.34%53.92M22.38%53.24M156.70%49.1M
Investing cash flow
Cash flow from continuing investing activities 219.46%99.48M5,353.53%19.33M183.61%43.61M508.56%62.16M-65.03%-25.63M-207.40%-83.28M-104.39%-368K-1,101.36%-52.16M-307.68%-15.22M-123.47%-15.53M
Net PPE purchase and sale -44.16%-15.33M89.71%-218K5.43%-3.87M-69.62%-2.7M-201.41%-8.55M29.85%-10.64M-17.80%-2.12M-20.57%-4.09M53.29%-1.59M56.80%-2.84M
Net business purchase and sale ---16.7M--0--0--0---16.7M--0--0--0--0--0
Net investment purchase and sale 281.05%131.52M1,017.20%19.55M198.78%47.48M576.04%64.86M97.01%-379K-178.36%-72.64M-82.80%1.75M-4,970.78%-48.07M-226.98%-13.63M-117.45%-12.69M
Cash from discontinued investing activities
Investing cash flow 219.46%99.48M5,353.53%19.33M183.61%43.61M508.56%62.16M-65.03%-25.63M-207.40%-83.28M-104.39%-368K-1,101.36%-52.16M-307.68%-15.22M-123.47%-15.53M
Financing cash flow
Cash flow from continuing financing activities -2,228.82%-369.63M-2,542.05%-51.65M-8,950.12%-257.48M-330.20%-57.51M-6.28%-2.99M109.49%17.36M-9.89%-1.96M89.76%-2.85M5,577.27%24.98M98.17%-2.82M
Net issuance payments of debt -382.97%-216.8M-77.81%-5M-7,195.98%-205.24M-104.41%-3.75M0.00%-2.81M142.38%76.62M0.00%-2.81M89.89%-2.81M3,123.57%85.05M98.09%-2.81M
Net common stock issuance -493.31%-148.33M---48.25M---50.04M-----------25M--0--0--------
Proceeds from stock option exercised by employees 113.53%3.3M84.37%1.72M100.04%12K---------613.92%-24.41M-18.00%934K-106,936.00%-26.71M-58.07%1.36M--0
Net other financing activities 20.71%-7.8M-63.64%-126K-108.29%-2.21M85.50%-5.29M-4,425.00%-181K-40.21%-9.84M27.36%-77K--26.68M---36.44M99.94%-4K
Cash from discontinued financing activities
Financing cash flow -2,228.82%-369.63M-2,542.05%-51.65M-8,950.12%-257.48M-330.20%-57.51M-6.28%-2.99M109.49%17.36M-9.89%-1.96M89.76%-2.85M5,577.27%24.98M98.17%-2.82M
Net cash flow
Beginning cash position 80.55%276.77M-40.00%147.59M21.63%300.48M54.09%283.61M80.55%276.77M47.21%153.3M148.15%245.97M184.59%247.05M417.80%184.05M47.21%153.3M
Current changes in cash -195.69%-118.15M-63.10%11.37M-13,965.07%-153.03M-73.54%16.67M-77.77%6.84M151.18%123.48M-43.13%30.81M-108.84%-1.09M22.89%63M144.83%30.75M
Effect of exchange rate changes ---77K---414K--133K----------0--0--0--------
End cash Position -42.72%158.55M-42.72%158.55M-40.00%147.59M21.63%300.48M54.09%283.61M80.55%276.77M80.55%276.77M148.15%245.97M184.59%247.05M417.80%184.05M
Free cash flow -23.55%136.66M40.17%43.47M14.32%56.96M-81.96%9.32M-41.83%26.91M28.15%178.75M-32.26%31.01M21.40%49.83M28.81%51.65M268.26%46.27M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 12 local time, U.S. Vice President Vance stated that negotiations between the United States and Iran failed to reach an agreement, Show More